Mirati Ther Performance
| MRTXDelisted Stock | USD 31.32 0.15 0.48% |
The company secures a Beta (Market Risk) of -0.51, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Mirati Ther are expected to decrease at a much lower rate. During the bear market, Mirati Ther is likely to outperform the market. Mirati Ther right now secures a risk of 0.0%. Please verify Mirati Ther treynor ratio, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Mirati Ther will be following its current price movements.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Mirati Ther has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Mirati Ther is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 413.7 M | |
| Total Cashflows From Investing Activities | 225.8 M |
Mirati |
Mirati Ther Relative Risk vs. Return Landscape
If you would invest 3,132 in Mirati Ther on August 28, 2024 and sell it today you would earn a total of 0.00 from holding Mirati Ther or generate 0.0% return on investment over 90 days. Mirati Ther is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Mirati, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Mirati Ther Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mirati Ther's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Mirati Ther, and traders can use it to determine the average amount a Mirati Ther's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| MRTX |
Based on monthly moving average Mirati Ther is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Mirati Ther by adding Mirati Ther to a well-diversified portfolio.
Mirati Ther Fundamentals Growth
Mirati Stock prices reflect investors' perceptions of the future prospects and financial health of Mirati Ther, and Mirati Ther fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Mirati Stock performance.
| Return On Equity | -0.7 | |||
| Return On Asset | -0.39 | |||
| Operating Margin | (10.49) % | |||
| Current Valuation | 3.19 B | |||
| Shares Outstanding | 70.15 M | |||
| Price To Earning | (3.97) X | |||
| Price To Book | 4.35 X | |||
| Price To Sales | 107.82 X | |||
| Revenue | 12.44 M | |||
| EBITDA | (759.59 M) | |||
| Cash And Equivalents | 1.19 B | |||
| Cash Per Share | 21.41 X | |||
| Total Debt | 51.51 M | |||
| Debt To Equity | 0.04 % | |||
| Book Value Per Share | 13.50 X | |||
| Cash Flow From Operations | (570.57 M) | |||
| Earnings Per Share | (12.18) X | |||
| Total Asset | 1.2 B | |||
| Retained Earnings | (2.45 B) | |||
| Current Asset | 125.4 M | |||
| Current Liabilities | 9.8 M | |||
About Mirati Ther Performance
Evaluating Mirati Ther's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Mirati Ther has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Mirati Ther has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. Mirati Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California. Mirati Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 413 people.Things to note about Mirati Ther performance evaluation
Checking the ongoing alerts about Mirati Ther for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Mirati Ther help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Mirati Ther is not yet fully synchronised with the market data | |
| Mirati Ther has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 12.44 M. Net Loss for the year was (740.87 M) with loss before overhead, payroll, taxes, and interest of (519.79 M). | |
| Mirati Ther currently holds about 1.19 B in cash with (570.57 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 21.41. | |
| Over 98.0% of the company shares are owned by institutional investors |
- Analyzing Mirati Ther's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Mirati Ther's stock is overvalued or undervalued compared to its peers.
- Examining Mirati Ther's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Mirati Ther's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Mirati Ther's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Mirati Ther's stock. These opinions can provide insight into Mirati Ther's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Consideration for investing in Mirati Stock
If you are still planning to invest in Mirati Ther check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Mirati Ther's history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |